© Insider Narrative. All Rights Reserved.
Wall Street Journal

Boston Scientific to Buy Penumbra for $15 Billion in Cash, Stock

This post was originally published on this site.

Boston Scientific has agreed to buy thrombectomy company Penumbra for about $15 billion in cash and stock in a deal that bolsters its cardiovascular portfolio.